Thin Composite -Wire -Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years
Open Access
- 10 May 2020
- journal article
- research article
- Published by Elsevier BV in КАРДИОЛОГИЯ УЗБЕКИСТАНА
- Vol. 13 (9), 1100-1109
- https://doi.org/10.1016/j.jcin.2020.01.230
Abstract
No abstract availableFunding Information
- Abbott Vascular
- Biotronik
- Medtronic
- Boston Scientific Corporation
This publication has 23 references indexed in Scilit:
- First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel DiameterJACC: Cardiovascular Interventions, 2017
- 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting StentJACC: Cardiovascular Interventions, 2017
- Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trialThe Lancet, 2016
- Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2016
- Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trialAmerican Heart Journal, 2016
- Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE TrialJournal of the American Heart Association, 2016
- Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trialThe Lancet, 2015
- Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trialThe Lancet, 2013
- Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificityEuroIntervention, 2010
- Clinical End Points in Coronary Stent TrialsCirculation, 2007